KOL KnockoutTM - Cataract Edition: More than Best Corrected -

KOL Knockout Cataract Edition More than Best Corrected Visual Acuity Meeting Patient Refractive Expectations Round 2

The live program has concluded.

If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.

Scroll back to top

Details

Overview
This popular CME program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the second of three rounds features Brett Mueller, DO, PhD; Taj Nasser, MD; and Evan D. Schoenberg, MD, as contestants.
Dr. Williamson will present complex cataract surgery case studies and the KOLs will weigh in on their preferred treatment option, leaving the audience to vote on the winner!
There will be learning, laughter, and only one KOL left standing!
This activity is supported by an independent educational grant from Alcon and Johnson & Johnson.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Explain how ocular surface disease may affect biometric measurements and postoperative refractive outcomes
- Compare current and emerging premium IOLs and summarize the latest data on potential outcomes achieved with different IOL technologies
- Discuss updates in surgical planning systems and new technologies used to improve refractive outcomes and provide better surgical efficiency during refractive cataract surgery
- Evaluate the potential benefits and drawbacks of using femtosecond laser technology for refractive cataract surgery
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Blake K. Williamson, MD, MPH, MS
Managing Partner
Williamson Eye Center and
Outpatient Surgery Center for Sight
Baton Rouge, LA

Brett Mueller, DO, PhD
Founder and Physician CEO
Mueller Vision
Fort Worth, TX

Taj Nasser, MD
Mueller Vision
Tylock-George Eyecare
Fort Worth, TX

Evan D. Schoenberg, MD
Cornea, Cataract, and Refractive Surgeon
Managing Partner
Georgia Eye Partners
Atlanta, GA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Blake K. Williamson, MD, MPH, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, BioTissue, Carl Zeiss Meditec, Diopsys, Eyevance, Glaukos, Johnson & Johnson Vision, New World Medical, Omeros, Shire, Sight Sciences, and Sun Pharma. Speaker’s Bureau: AbbVie, Allergan, Glaukos, New World Medical, and TearLab.
Brett Mueller, DO, PhD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Carl Ziess Meditec, Glaukos, Johnson & Johnson Vision, LumiBird, RxSight, STAAR Surgical, and Tarsus Pharmaceuticals.
Taj Nasser, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, STAAR Surgical, and Tarsus Pharmaceuticals. Grant/Research Support: STAAR Surgical.
Evan D. Schoenberg, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Lensar. Speaker's Bureau: Dompé, Glaukos, and Johnson & Johnson Vision.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Alcon, or Johnson & Johnson.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date: 10/17/2024

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Title

Share on ReachMD